Keyphrases
Acute Kidney Injury
35%
Antibiotic Policy
22%
Antibiotic Prescribing
56%
Antibiotic Resistance
22%
Antibiotic Use
73%
Antibiotics
75%
Antimicrobial
45%
Antimicrobial Resistance
34%
Antimicrobial Stewardship
25%
Antimicrobial Stewardship Program
31%
Antimicrobial Use
100%
Care Bundle
16%
Ciprofloxacin
25%
Clinical Outcomes
19%
Clinical Teams
18%
Clostridium Difficile Infection
43%
Community-acquired Pneumonia
31%
Confidence Interval
27%
Consumption Point
26%
European Countries
17%
European Hospital
26%
General Practice
27%
Gentamicin
17%
High Risk
19%
High-risk Prescribing
18%
Hospital Inpatients
39%
Hospitalization
24%
Inter-rater Reliability
20%
Interrupted Time Series
35%
Junior Doctors
25%
Medical Students
23%
Methicillin-resistant Staphylococcus Aureus
27%
Nested Case-control Study
18%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
35%
Odds Ratio
19%
Older People
20%
Point Prevalence Survey
37%
Prescribing Errors
18%
Prescribing Practices
24%
Primary Care
50%
Public Knowledge
18%
Randomized Controlled Trial
23%
Scotland
61%
Scottish
33%
Segmented Regression Analysis
17%
Sepsis
26%
Tayside
47%
Third-generation Cephalosporins
17%
Trimethoprim
43%
Urinary Tract Infection
33%
Nursing and Health Professions
Acute Kidney Failure
9%
Antibiotic Resistance
33%
Antiinfective Agent
60%
Antimicrobial Resistance
22%
Antimicrobial Stewardship
47%
Bloodstream Infection
22%
Care Bundle
16%
Cephalosporin Derivative
10%
Clinical Audit
11%
Clinical Outcome
14%
Clostridium Difficile Infection
11%
Cohort Analysis
20%
Community Acquired Pneumonia
32%
Compliance
20%
Confidence Interval
20%
Cost Effectiveness Analysis
18%
Disease
8%
Drug Therapy
14%
General Practice
10%
General Practitioner
20%
Health Care Cost
10%
Health Practitioner
9%
Health Service
13%
Hospital Inpatient
27%
Hospitalization
21%
Infection
37%
Interrater Reliability
12%
Medical Student
21%
Methicillin-Resistant Staphylococcus Aureus
13%
Mortality
12%
Multivariate Analysis
8%
Nonsteroid Antiinflammatory Agent
18%
Odds Ratio
12%
Patient Care
13%
Patient Safety
18%
Perioperative
12%
Physician
54%
Practice Guideline
16%
Prevalence
35%
Primary Medical Care
46%
Sepsis
35%
Soft Tissue Infection
12%
Systematic Review
15%
Time Series Analysis
37%
Total Quality Management
59%
Treatment Outcome
8%
Trimethoprim
32%
Urinary Tract Infection
26%
Urine Sampling
13%
Ward
25%
Pharmacology, Toxicology and Pharmaceutical Science
4 Aminobutyric Acid
14%
Acute Kidney Failure
21%
Adverse Drug Reaction
14%
Amoxicillin
9%
Amoxicillin Plus Clavulanic Acid
9%
Antibiotic Prophylaxis
8%
Antibiotic Resistance
39%
Antibiotics
64%
Antiinfective Agent
94%
Antimicrobial Resistance
25%
Antimicrobial Therapy
8%
Biphenyl
12%
Bloodstream Infection
28%
Case-Control Study
25%
Cephalosporin Derivative
9%
Ciprofloxacin
25%
Clostridium Difficile Infection
44%
Cohort Study
33%
Comorbidity
9%
Congestive Heart Failure
9%
Defined Daily Dose
17%
Disease
15%
Epidemiology
7%
Escherichia coli
16%
Flucloxacillin
13%
Gentamicin
17%
Hospital Infection
8%
Infection
49%
Lower Respiratory Tract Infection
10%
Medication Error
12%
Methicillin-Resistant Staphylococcus Aureus
23%
Meticillin
8%
Mortality
12%
Non-Steroidal Anti-Inflammatory Drug
35%
Observational Study
14%
Potassium Acetate
12%
Prevalence
66%
Quinolone Derivative
21%
Randomized Controlled Trial
15%
Receptor
9%
Respiratory Tract
7%
Sepsis
18%
Soft Tissue Infection
14%
Staphylococcus Aureus
12%
Surgical Prophylaxis
10%
Third Generation Cephalosporin
13%
Trimethoprim
30%
Ulcer Healing
7%
Urinary Tract Infection
29%
Warfarin
9%